Expression Pattern and Clinical Value of Key m6A RNA Modification Regulators in Abdominal Aortic Aneurysm

References

• van de Luijtgaarden KM, Heijsman D, Maugeri A, et al. First genetic analysis of aneurysm genes in familial and sporadic abdominal aortic aneurysm. Hum Genet. 2015;134(8):881–893. doi:10.1007/s00439-015-1567-0
   PubMed Web of Science ®Google Scholar
• Liu Y, Wang X, Wang H, Hu T. Identification of key genes and pathways in abdominal aortic aneurysm by integrated bioinformatics analysis. J Int Med Res. 2020;48(4):300060519894437.
   PubMedGoogle Scholar
• Yuan Z, Lu Y, Wei J, Wu J, Yang J, Cai Z. Abdominal aortic aneurysm: roles of inflammatory cells. Front Immunol. 2020;11:609161. doi:10.3389/fimmu.2020.609161
   PubMed Web of Science ®Google Scholar
• Hou Y, Guo W, Fan T, et al. Advanced research of abdominal aortic aneurysms on metabolism. Front Cardiovasc Med. 2021;8:630269. doi:10.3389/fcvm.2021.630269
   PubMed Web of Science ®Google Scholar
• Wang L, Liu S, Pan B, et al. The role of autophagy in abdominal aortic aneurysm: protective but dysfunctional. Cell Cycle. 2020;19(21):2749–2759. doi:10.1080/15384101.2020.1823731
   PubMed Web of Science ®Google Scholar
• He PC, He C. m(6) A RNA methylation: from mechanisms to therapeutic potential. EMBO J. 2021;40(3):e105977. doi:10.15252/embj.2020105977
   PubMed Web of Science ®Google Scholar
• Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640–650. doi:10.1016/j.molcel.2019.04.025
   PubMed Web of Science ®Google Scholar
• Yang Y, Hsu PJ, Chen YS, Yang YG. Dynamic transcriptomic m(6)A decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018;28(6):616–624. doi:10.1038/s41422-018-0040-8
   PubMed Web of Science ®Google Scholar
• Han Z, Yang B, Wang Q, Hu Y, Wu Y, Tian Z. Comprehensive analysis of the transcriptome-wide m(6)A methylome in invasive malignant pleomorphic adenoma. Cancer Cell Int. 2021;21(1):142. doi:10.1186/s12935-021-01839-6
   PubMed Web of Science ®Google Scholar
• Han J, Wang JZ, Yang X, et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner. Mol Cancer. 2019;18(1):110. doi:10.1186/s12943-019-1036-9
   PubMed Web of Science ®Google Scholar
• Su Y, Huang J, Hu J. m(6)A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gastric cancer. Front Oncol. 2019;9:1038. doi:10.3389/fonc.2019.01038
   PubMed Web of Science ®Google Scholar
• Wang H, Xu B, Shi J. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2. Gene. 2020;722:144076. doi:10.1016/j.gene.2019.144076
   PubMed Web of Science ®Google Scholar
• Qin Y, Li L, Luo E, et al. Role of m6A RNA methylation in cardiovascular disease (review). Int J Mol Med. 2020;46(6):1958–1972. doi:10.3892/ijmm.2020.4746
   PubMed Web of Science ®Google Scholar
• He Y, Xing J, Wang S, Xin S, Han Y, Zhang J. Increased m6A methylation level is associated with the progression of human abdominal aortic aneurysm. Ann Transl Med. 2019;7(24):797. doi:10.21037/atm.2019.12.65
   PubMed Web of Science ®Google Scholar
• Zhong L, He X, Song H, et al. METTL3 induces AAA development and progression by modulating N6-methyladenosine-dependent primary miR34a processing. Mol Ther Nucleic Acids. 2020;21:394–411. doi:10.1016/j.omtn.2020.06.005
   PubMedGoogle Scholar
• Fang X, Duan SF, Gong YZ, Wang F, Chen XL. Identification of key genes associated with changes in the host response to severe burn shock: a bioinformatics analysis with data from the gene expression omnibus (GEO) database. J Inflamm Res. 2020;13:1029–1041. doi:10.2147/JIR.S282722
   PubMed Web of Science ®Google Scholar
• Deng S, Zhang H, Zhu K, et al. M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers. Brief Bioinform. 2020;22(3):bbaa055.
   Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782–795. doi:10.1016/j.immuni.2013.10.003
   PubMed Web of Science ®Google Scholar
• Wu S, Zhang S, Wu X, Zhou X. m(6)A RNA methylation in cardiovascular diseases. Mol Ther. 2020;28(10):2111–2119. doi:10.1016/j.ymthe.2020.08.010
   PubMed Web of Science ®Google Scholar
• Patil DP, Chen CK, Pickering BF, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369–373. doi:10.1038/nature19342
   PubMed Web of Science ®Google Scholar
• Guo W, Huai Q, Zhang G, et al. Elevated heterogeneous nuclear ribonucleoprotein C expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma. Front Oncol. 2020;10:598437. doi:10.3389/fonc.2020.598437
   PubMed Web of Science ®Google Scholar
• Wang Q, Zhang Q, Li Q, Zhang J, Zhang J. Clinicopathological and immunological characterization of RNA m(6) A methylation regulators in ovarian cancer. Mol Genet Genomic Med. 2021;9(1):e1547. doi:10.1002/mgg3.1547
   PubMed Web of Science ®Google Scholar
• Fang J, Hu M, Sun Y, Zhou S, Li H. Expression profile analysis of m6A RNA methylation regulators indicates they are immune signature associated and can predict survival in kidney renal cell carcinoma. DNA Cell Biol. 2020;39(12):2194–2211. doi:10.1089/dna.2020.5767
   Web of Science ®Google Scholar
• Li Z, Kong W. Cellular signaling in abdominal aortic aneurysm. Cell Signal. 2020;70:109575. doi:10.1016/j.cellsig.2020.109575
   PubMed Web of Science ®Google Scholar
• Zhang W, Cheng W, Parlato R, et al. Nucleolar stress induces a senescence-like phenotype in smooth muscle cells and promotes development of vascular degeneration. Aging (Albany NY). 2020;12(21):22174–22198.
   PubMedGoogle Scholar
• Harada T, Yoshimura K, Yamashita O, et al. Focal adhesion kinase promotes the progression of aortic aneurysm by modulating macrophage behavior. Arterioscler Thromb Vasc Biol. 2017;37(1):156–165. doi:10.1161/ATVBAHA.116.308542
   PubMed Web of Science ®Google Scholar
• Xu B, Li G, Guo J, et al. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms. J Vasc Surg. 2021;S0741-5214(21)00195-6. doi:10.1016/j.jvs.2021.01.051
   Web of Science ®Google Scholar
• Qureshi MI, Greco M, Vorkas PA, Holmes E, Davies AH. Application of metabolic profiling to abdominal aortic aneurysm research. J Proteome Res. 2017;16(7):2325–2332. doi:10.1021/acs.jproteome.6b00894
   PubMed Web of Science ®Google Scholar
• Wu QY, Cheng Z, Zhou YZ, et al. A novel STAT3 inhibitor attenuates angiotensin II-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy. Cell Death Dis. 2020;11(2):131. doi:10.1038/s41419-020-2326-2
   PubMed Web of Science ®Google Scholar
• Ramadan A, Singh KK, Quan A, et al. Loss of vascular smooth muscle cell autophagy exacerbates angiotensin II-associated aortic remodeling. J Vasc Surg. 2018;68(3):859–871. doi:10.1016/j.jvs.2017.08.086
   PubMed Web of Science ®Google Scholar
• Giusti B, Saracini C, Bolli P, et al. Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm. J Med Genet. 2008;45(11):721–730. doi:10.1136/jmg.2008.057851
   PubMed Web of Science ®Google Scholar
• Golledge J, Biros E, Warrington N, et al. A population-based study of polymorphisms in genes related to sex hormones and abdominal aortic aneurysm. Eur J Hum Genet. 2011;19(3):363–366. doi:10.1038/ejhg.2010.182
   PubMed Web of Science ®Google Scholar
• Legaki E, Klonaris C, Athanasiadis D, et al. DAB2IP expression in abdominal aortic aneurysm: EZH2 and mir-363-3p as potential mediators. In Vivo (Brooklyn). 2019;33(3):737–742. doi:10.21873/invivo.11533
   Web of Science ®Google Scholar
• Xia Q, Zhang J, Han Y, et al. Epigenetic regulation of regulatory T cells in patients with abdominal aortic aneurysm. FEBS Open Bio. 2019;9(6):1137–1143. doi:10.1002/2211-5463.12643
   PubMed Web of Science ®Google Scholar
• Wang W, Xu B, Xuan H, et al. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease. J Vasc Surg. 2018;68(5):1538–1550e1532. doi:10.1016/j.jvs.2017.09.030
   PubMed Web of Science ®Google Scholar
• Ni XQ, Lu WW, Zhang JS, et al. Inhibition of endoplasmic reticulum stress by intermedin1-53 attenuates angiotensin II-induced abdominal aortic aneurysm in ApoE KO mice. Endocrine. 2018;62(1):90–106. doi:10.1007/s12020-018-1657-6
   PubMed Web of Science ®Google Scholar
• Xu B, Iida Y, Glover KJ, et al. Inhibition of VEGF (vascular endothelial growth factor)-A or its receptor activity suppresses experimental aneurysm progression in the aortic elastase infusion model. Arterioscler Thromb Vasc Biol. 2019;39(8):1652–1666. doi:10.1161/ATVBAHA.119.312497
   PubMed Web of Science ®Google Scholar
• Liang ES, Bai WW, Wang H, et al. PARP-1 (poly[ADP-ribose] polymerase 1) inhibition protects from ang II (angiotensin II)-induced abdominal aortic aneurysm in mice. Hypertension. 2018;72(5):1189–1199. doi:10.1161/HYPERTENSIONAHA.118.11184
   PubMed Web of Science ®Google Scholar
• Slusarz A, Pulakat L. The two faces of miR-29. J Cardiovasc Med (Hagerstown). 2015;16(7):480–490. doi:10.2459/JCM.0000000000000246
   PubMed Web of Science ®Google Scholar
• Chen WW, Qi JW, Hang Y, et al. Simvastatin is beneficial to lung cancer progression by inducing METTL3-induced m6A modification on EZH2 mRNA. Eur Rev Med Pharmacol Sci. 2020;24(8):4263–4270.
   PubMed Web of Science ®Google Scholar
• Kisliouk T, Rosenberg T, Ben-Nun O, Ruzal M, Meiri N. Early-life m6A RNA demethylation by fat mass and obesity-associated protein (FTO) influences resilience or vulnerability to heat stress later in life. eNeuro. 2020;7(3):ENEURO.0549–19.2020. doi:10.1523/ENEURO.0549-19.2020
   PubMed Web of Science ®Google Scholar
• Dixit D, Prager BC, Gimple RC, et al. The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells. Cancer Discov. 2021;11(2):480–499. doi:10.1158/2159-8290.CD-20-0331
   PubMed Web of Science ®Google Scholar
• Yang L, Chen Y, Liu N, et al. Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N(6)-methyladenosine of PARP1 mRNA and downregulating PTEN. J Hematol Oncol. 2021;14(1):46. doi:10.1186/s13045-021-01059-5
   PubMed Web of Science ®Google Scholar
• Tian L, Hu X, He Y, Wu Z, Li D, Zhang H. Construction of lncRNA-miRNA-mRNA networks reveals functional lncRNAs in abdominal aortic aneurysm. Exp Ther Med. 2018;16(5):3978–3986.
   PubMed Web of Science ®Google Scholar
• Liu X, Xiao M, Zhang L, et al. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway. J Clin Lab Anal. 2021;35(3):e23655. doi:10.1002/jcla.23655
   PubMed Web of Science ®Google Scholar
• Gu C, Wang Z, Zhou N, et al. Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of notch1. Mol Cancer. 2019;18(1):168. doi:10.1186/s12943-019-1084-1
   PubMed Web of Science ®Google Scholar
• Ma JZ, Yang F, Zhou CC, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing. Hepatology. 2017;65(2):529–543. doi:10.1002/hep.28885
   PubMed Web of Science ®Google Scholar
• Chen X, Xu M, Xu X, et al. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer. 2020;19(1):106. doi:10.1186/s12943-020-01220-7
   PubMed Web of Science ®Google Scholar
• Yang X, Zhang S, He C, et al. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST. Mol Cancer. 2020;19(1):46. doi:10.1186/s12943-020-1146-4
   PubMed Web of Science ®Google Scholar